Related Experiment Video
Updated: Mar 26, 2026
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Glucose-functionalized amino-OPEs as biocompatible photosensitizers in PDT
Elisa Deni1, Alicia Zamarrón2, Paola Bonaccorsi1
1Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy.
Abstract:
Photodynamic therapy (PDT) is a minimally invasive procedure that can provide a selective eradication of neoplastic diseases by the combined effect of a photosensitizer, light and oxygen. New amino oligo(phenylene-ethynylene)s (OPEs), bearing hydrophilic glucoside terminations, have been prepared, characterized and tested as photosensitizers in PDT. The effectiveness of these compounds in combination with UVA light has been checked on two tumor cell lines (HEp-2 and HeLa cells, derived from a larynx carcinoma and a cervical carcinoma, respectively). The compounds triggered a mitotic blockage that led to the cell death, being the effect active up to 3 μm concentration. The photophysical properties of OPEs, such as high quantum yield, stability, singlet oxygen production, biocompatibility, easy cell-internalization and very good response even at low concentration, make them promising photosensitizers in the application of PDT.
Insights
New photosensitizers based on amino oligo(phenylene-ethynylene)s (OPEs) show promise for photodynamic therapy (PDT). These compounds effectively induce cancer cell death with UVA light, even at low concentrations.
Area of Science:
- Medicinal Chemistry
- Photodynamic Therapy
- Organic Synthesis
Background:
- Photodynamic therapy (PDT) offers selective cancer treatment using photosensitizers, light, and oxygen.
- Developing novel photosensitizers with improved efficacy and biocompatibility is crucial for advancing PDT.
Purpose of the Study:
- To synthesize and characterize novel amino oligo(phenylene-ethynylene)s (OPEs) with glucoside terminations.
- To evaluate the potential of these OPEs as photosensitizers in photodynamic therapy (PDT).
Main Methods:
- Synthesis and characterization of new amino oligo(phenylene-ethynylene)s (OPEs).
- Testing OPEs as photosensitizers in combination with UVA light on HEp-2 and HeLa tumor cell lines.
- Assessment of photophysical properties including quantum yield and singlet oxygen production.
Main Results:
- The synthesized OPEs demonstrated effectiveness as photosensitizers against larynx and cervical carcinoma cell lines.
- The compounds induced mitotic blockage leading to cell death at concentrations up to 3 μm.
- OPEs exhibited favorable photophysical properties, including high quantum yield and singlet oxygen production.
Conclusions:
- Amino oligo(phenylene-ethynylene)s (OPEs) are promising candidates for photodynamic therapy (PDT) applications.
- Their biocompatibility, cell internalization, and efficacy at low concentrations support their potential in cancer treatment.
